| Name | Title | Contact Details |
|---|
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.
Capistrano Lab Inc is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Greiner Vacuette North America is a Monroe, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Q Macs is a Richardson, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pacesetter Medical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.